Astrid M. Berthe

Medtronic ATS Medical, Inc. develops, manufactures and markets medical devices for the treatment of structural heart disease. The company was founded on November 09, 2000 and is headquartered in Minneapolis, MN.

Uptake Medical Corp. develops medical technologies for the treatment of lung diseases. It provides InterVapor, an endoscopic lung volume reduction solution for people with severe emphysema that uses the body’s natural healing process without leaving implants or foreign materials in the lung; and InterVapor Personalized Procedure Program, a proprietary application that recommends treatment locations and ablation energy durations for each patient based on the patient’s CT scan. The company was founded by Robert L. Barry in 2004 and is headquartered in Tustin, CA.

Oraya Therapeutics, Inc. develops and commercializes a non-invasive therapy for wet age-related macular degeneration. The firm delivers a precise dose of radiation non-invasively to the macula using an automated positioning system and a localizing algorithm. The company was founded by Michael E. Gertner in 2006 and is headquartered in Newark, CA.

IsoTis Orthobiologics Inc. develops, manufactures and markets proprietary products for the treatment of musculoskeletal diseases and disorders. Its products include bone graft substitutes that promote the regeneration of bone and are used to repair natural, trauma-related and surgically-created defects common in orthopedic procedures, including spinal fusions. The company was founded in 2003 and is headquartered in Irvine, CA.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL.

MiCardia Corp. designs, develops, and commercializes implantable medical devices. The firm offers implantable devices for the treatment of heart diseases, such as mitral valve regurgitation and congestive heart failure. It also provides enCor, an annuloplasty device that corrects residual mitral regurgitation on a beating heart. The company was founded in November 2004 by Michael R. Henson, Shawn Moaddeb and Samuel M. Shaolian and is headquartered in Irvine, CA.

3F Therapeutics, Inc. develops, manufactures, and markets cardiovascular devices. The firm's products include Aortic Bioprosthesis, a biological replacement aortic heart valve to maintain flow characteristics after implant. The company was founded by Theodore C. Skokos in 1998 and is headquartered in Lake Forest, CA.